Gabapentin prescriptions have drastically increased in the US due to off-labelprescribing in settings such as opioid use disorder (OUD) treatment to manage a rangeof comorbid conditions and withdrawal symptoms, despite a lack of evidence.
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder (Links to an external site)
